TONI HYLTON: Open Payments
NPI 1366764060 · JAMAICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 50 payments from 11 companies in 2025. Trend: 2023 $2,193 · 2024 $3,192 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 19 | $470 |
| Gilead Sciences, Inc. | 9 | $271 |
| Novo Nordisk Inc | 5 | $124 |
| Merck Sharp & Dohme LLC | 5 | $109 |
| ABBVIE INC. | 3 | $75 |
| CSL Behring | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: APRETUDE, CABENUVA, PIFELTRO, Ozempic, Andembry, AIRSUPRA, MOUNJARO, UBRELVY.
Industry payments across NY — which companies pay providers there.
